Tag: migraine

Pharmacology News Digest, July 22nd 2018

Continue reading “Pharmacology News Digest, July 22nd 2018”

Advertisements

Pharmacology News Digest, July 15th

Continue reading “Pharmacology News Digest, July 15th”

First Antibody Therapy Approved for Migraine Headaches | FDA

The US FDA has approved the first antibody therapy, erenumab (Aimovig®) for the prevention of migraine headaches.

Key Points

  • Human monoclonal antibody
  • Calcitonin-gene related peptide (CGRP) antagonist
  • 1-2.5 fewer migraines/month
  • Once-monthly self-injectable
  • $6900/year before insurance and discounts
  • Adverse effects: Injection site reactions and constipation

Continue reading “First Antibody Therapy Approved for Migraine Headaches | FDA”